Site icon Conservation news

Shark fin does not cure cancer

Shark fin does not cure cancer

Shark fin does not cure cancer
Study reports shark cartilage does not help fight lung cancer
mongabay.com
June 3, 2007

Shark cartilage, long believed in traditional medicine to be an anti-cancer agent, confers no health benefits in surviving lung cancer reports an extensive study presented at the 43rd annual meeting of the American Society of Clinical Oncology.

Shark cartilage extract, AE-941 or Neovastat, did not offer health improvement versus a placebo in a trial of 384 newly-diagnosed untreated Stage III non-small cell lung cancer patients who also underwent chemotherapy and radiation treatment.



“Clearly, these results demonstrate that AE-941 is not an effective therapeutic agent for lung cancer,” said Charles Lu, M.D., lead author of the study and associate professor at the University of Texas M. D. Anderson Cancer Center. “So, too, these findings have to cast major skepticism on shark cartilage products that are being sold for profit and have no data to support their efficacy as cancer-fighting agent.”

Photo by Rhett A. Butler

Lu warned that patients currently taking shark cartilage should not expect the therapy alone to be beneficial.

“We have absolutely no data showing improvements in survival, tumor shrinkage and/or clinical benefits to patients,” said Lu. “Now when patients ask their oncologists about shark cartilage, physicians can point to this large NCI-sponsored Phase III trial and tell patients that, at this point, the only studies that have been done with cartilage-derived products have been negative.”



Sharks are widely harvested for their fins which are believed to bring luck and health benefits in some cultures. A Science study last year estimated that 26-73 million sharks are killed a year for their fins.



User comments



Exit mobile version